ATC level 4
J06BDImmunoglobulin therapy, subgroup J06BD
- Molecules
- 5
- Subgroups
- 5
ATC J06BD (Immunoglobulin therapy, subgroup J06BD) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 5 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J06BD.
- AnsuvimabOrphanZaire Ebolavirus Glycoprotein-directed Antibody1 presentation1 brandJ06BD04
- ClesrovimabBiologicRespiratory Syncytial Virus Anti-F Protein Monoclonal Antibody1 presentation1 brandJ06BD10
- NirsevimabBiologicRespiratory Syncytial Virus Anti-F Protein Monoclonal Antibody2 presentations2 brandsJ06BD08
- Palivizumab1 brandJ06BB16
- Sipavibart1 brandJ06BD09
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.